We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Macrophage Migration Inhibitory Factor (MIF) suppresses mitophagy through disturbing the protein interaction of PINK1-Parkin in sepsis-associated acute kidney injury
Summary
This biomedical study investigated how an inflammatory protein (MIF) suppresses the protective cell process of mitophagy in sepsis-related kidney injury. This is a medical research paper on kidney disease mechanisms with no connection to environmental microplastics.
Abstract Renal tubular epithelial cells (RTECs) injury foreboded the occurrence and development of sepsis-associated acute kidney injury (SA-AKI). Recent studies of mitochondria have demonstrated that mitophagy was an indispensable physiological function of alleviating RTECs injury. Mitophagy was suppressed progressively by the inflammation response in SA-AKI. However, the mechanism of inflammation modulating mitophagy remains poor understood. We investigated the role of macrophage migration inhibitory factor (MIF, a pro-inflammation protein) in the PINK1-Parkin pathway of mitophagy through identifying the protein-protein interactions under the condition of inhibiting or over-expressing MIF. Unexpectedly, increasing MIF directly bound with PINK1 and disturbed the interaction of PINK1 and Parkin, which restrained the Parkin recruitment to mitochondria and the occurrence of mitophagy. Furthermore, this effect caused severe RTECs apoptosis, but which could be reversed by a MIF inhibitor ISO-1 or/and a new mitophagy activator T0467. These findings identified a critical renodamaged effect of MIF on disturbing the interaction of PINK1-Parkin and a therapeutic effect of ISO-1 and T0467 on protecting against SA-AKI. This study provided a novel insight of treating SA-AKI through targeting MIF and mitophagy.
Sign in to start a discussion.
More Papers Like This
Sotagliflozin prevents acute kidney injury by suppressing oxidative stress, inflammation, and apoptosis in renal ischemia/reperfusion rat model
This study found that sotagliflozin, a dual SGLT1/2 inhibitor, protects against acute kidney injury in rats by reducing oxidative stress, inflammation, and cell death in a renal ischemia/reperfusion model. While not directly about microplastics, the study is relevant to understanding kidney protection mechanisms, as microplastics have been detected in kidney tissue and may contribute to renal inflammation.
Acute kidney injury: exploring endoplasmic reticulum stress-mediated cell death
This review examines how endoplasmic reticulum stress, a cellular response to accumulated misfolded proteins, can trigger various forms of cell death in acute kidney injury. While not directly about microplastics, these same stress pathways are activated when cells are exposed to nanoplastics, which have been shown to accumulate in kidney tissue. Understanding these mechanisms helps explain how microplastic exposure could contribute to kidney damage at the cellular level.
Toxicological effects of microplastics in renal ischemia–reperfusion injury
Researchers studied how microplastic exposure affects kidney injury and recovery in a mouse model of reduced blood flow to the kidneys. They found that microplastics worsened kidney damage by triggering inflammatory responses and disrupting cellular repair processes. The study suggests that microplastic accumulation in the body may increase vulnerability to kidney complications.
Research progress on damage-associated molecular patterns in acute kidney injury
This review explores how damage-associated molecular patterns (DAMPs), molecules released by injured cells, drive inflammation in acute kidney injury. The authors note that environmental stressors including microplastics can trigger DAMP release, which activates immune pathways that worsen kidney damage. Understanding these molecular mechanisms could lead to new therapeutic strategies for preventing kidney injury progression.
The detrimental effects of microplastic exposure on kidney function
This review explores the two-way relationship between kidney function and microplastic exposure, asking whether MPs can be cleared renally and whether kidney disease impairs their clearance. Evidence suggests MPs accumulate in kidney tissue and may contribute to disease progression, though clinical data remain limited.